Related Experiment Videos
Indirect myocardial revascularization--an experimental study in the dog
Summary
Free skeletal muscle flap grafting onto the canine heart creates functional myocardial revascularization. This surgical technique promotes new blood vessel growth, improving blood flow to the heart muscle.
Area of Science:
- Cardiovascular Surgery
- Regenerative Medicine
- Myocardial Revascularization
Background:
- Previous studies indicate skeletal muscle flap grafting can achieve myocardial revascularization.
- The functional capacity of neovessels formed by this grafting technique requires further evaluation.
Purpose of the Study:
- To assess the functional significance of neovessels created by grafting a free skeletal muscle flap onto the canine heart.
- To evaluate regional myocardial blood flow under conditions of coronary artery occlusion and collateral flow enhancement.
Main Methods:
- Five dogs underwent LAD (left anterior descending coronary artery) Ameroid constrictor implantation and simultaneous free muscle flap grafting.
- Arterial anastomosis was performed using the internal mammary artery, with venous drainage into the right atrium.
- Regional myocardial blood flow was measured using the radioactive microsphere technique under various coronary occlusion scenarios, including "preconditioning".
Main Results:
- Despite complete LAD occlusion, antero-lateral myocardial blood flow remained unchanged, indicating functional revascularization from the graft.
- Blood flow in the circumflex artery (CX) territory was minimal during occlusion.
- "Preconditioning" improved perfusion in the epicardial regions supplied by the CX.
- Histological examination revealed large sinusoid-like blood conductors connecting the graft to the heart.
Conclusions:
- Grafting a free skeletal muscle flap onto the canine heart successfully establishes functional myocardial revascularization.
- The neovessels formed are capable of sustaining regional myocardial blood flow during coronary artery occlusion.
- This technique holds promise for treating ischemic heart disease.